FdaApplication
NDA 213246
Identifiers
- fda_app_no: NDA213246
Properties
| Property | Value |
|---|---|
| applicant_name | ELI LILLY AND CO |
| application_type | NDA |
| approval_date | 2020-05-08 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RETEVMO | SELPERCATINIB | 40MG | CAPSULE;ORAL |
| RETEVMO | SELPERCATINIB | 80MG | CAPSULE;ORAL |
2 products